Industrial scale of Chitin production for the raw material of Glocosamne production project

The first Chtin and Chitosan production plant construction, in proposes for expanding capacity under Bannawach Bio-Line Co.,Ltd.

• A member of the R&D team in part of Chitosan preparation for enhanced Chitosan derivative for a dietary supplement, L112 Biopolymer and Chitosan spec L112 in research and development of;

Optimizing chitosan characteristics for effective use in human weight-loss regimens
Phase I & II study Chitosan of interest
Phase III study: Chitosan of interest in rats

• Investment in equipment, machinery, lab-room, lab equipment, and clean-room class 100k environment for manufacturing L112 Biopolymer and Chitosan in medical device grade and food grade included implementing the QMS (Quality Management System)

• Manufacturer Chitosan purpose for export and material to produce L112 Biopolymer

• Manufacturer L112 Biopolymer export to USA which re-export to EU finished-product wide-popular in EU countries

• Produce Chitin export to Japan, we have expanded Chitin production capacity to the Indonesia factory

• Mr. Kasem and Mr. Paisan have chosen to walk away from the Bannawach Bio-line factory for shareholder reasons. Then Bio21 was established along with the first strategic planned "we are one of the Specialist Chitosan Manufacturer"

• Continue research and development in Chitosan and L112 Biopolymer

• Launch finished-product L112 Absorbital, a natural fiber fat binding tablets and capsule type for a human consumption

• Continue in Chitosan applications R&D, manufacturing and selling Chitosan and Chitosan applications

2010: Start a new Chitosan factory in Samutsakorn province for marketing and selling proposes in EU, USA Asia markets and Launch New L112 Absorbital and Advance-L112 Absorbital products

2012: Start the food-grade / dietary supplement Chitosan and medical device Chitosan for JAPAN and ASIAN

2013: Launch a new Chitosan application in the agricultural product "FCR additive" for broiler farm by R&D including a test run at the prototype farm (EVAP farm system)

2014: Restart the dietary supplement / medical device Chitosan business with a customer from an EU country

2015: The second Chitosan factory in Banyuwangi Indonesia is ready for production of industrial grade and food grade Chitosan.

2018: Signed the Agreement on quality assurance for Chitosan supplies for EU customer, and started production of fish scale OSSEIN at Indonesia factory, purposes for commercial and in-house used in Collagen production in the future.

2019: Started production of fish scale OSSEIN in Thailand factory and started a pilot scale of fish scale Collagen by using the OEM

2020: Implement and launch L112 Polymer product for Broiler Farming, Poultry Farming (Layer chicken Farming), and Pig Farming

2021: The optimized production capacity of OSSEIN (Decalcified fish scale) products is 240-360 MT per year.

2022: Time to global GMP/HACCP factory

We have started preparing for the future; in 2023 will be the 2nd chance time for the small ways of BIO21 to go global; we are cooperating with the crab meat factory with the HACCP and EU certificate. We use fresh crab shells (almost the snow crab shells) directly from the food processing line to produce CHITIN and CHITOSAN. And it is also time to implement the quality systems QMS, HACCP, EU, and ISO series with certification.

2024: Live the GMP/HACCP Chitosan manufacturing plant

March 2024; the new CHITOSAN production plant ready to production with a capacity approximately 60-80 MT per year